STAQ Pharma, Inc. recalls ROPivacaine HCl 0.2% PF in Sodium Chloride 1
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
- Products
-
- ROPivacaine HCl 0.2% PF in Sodium Chloride 1
- Company
- STAQ Pharma, Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 2616 bags
- About this recall
- ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ Pharma Inc. 14135 E 42nd Ave, Unit 50, Denver, Colorado 80239, NDC 73177-0109-26,